Abstract
Quality-assured local and regional hyperthermia procedures have been proven to enhance the clinical benefits of oncological standard treatments in several clinical settings without a substantial increase of late toxicity. This makes hyperthermia an attractive sensitizer for both radiotherapy and chemotherapy. It is no longer the question whether hyperthermia is an effective oncological treatment at all. Currently, the question is which patient, which tumor entity, and which clinical stage of disease benefit most from additional hyperthermia as integral part of current multimodality oncological standard treatment schedules. This remains particularly true for patients with recurrent malignant diseases and a previous irradiation series in the involved area.
The original version of this chapter was revised. An erratum to this chapter can be found at 10.1007/978-3-319-41825-4_78.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Angele MK, Albertsmeier M, Prix NJ, Hohenberger P, Abdel-Rahman S, Dieterle N et al (2014) Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg 260:749–754; discussion 54–6
Berdov BA, Menteshashvili GZ (1990) Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 6:881–890
Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J et al (2012) Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: quality management in regional deep hyperthermia. Strahlenther Onkol 188(Suppl 2):198–211
Colombo R, Da Pozzo LF, Salonia A, Rigatti P, Leib Z, Baniel J et al (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21:4270–4276
Cornett WR, McCall LM, Petersen RP, Ross MI, Briele HA, Noyes RD et al (2006) Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol 24:4196–4201
Datta NR, Bose AK, Kapoor HK, Gupta S (1990) Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 6:479–486
De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, Lutgens L, Lammering G, van Mastrigt GA et al (2009) Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev (3):CD006269
Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW et al (2008) Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 15:1937–1947
Franckena M, De Wit R, Ansink AC, Notenboom A, Canters RA, Fatehi D et al (2007) Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area. Int J Hyperthermia 23:443–450
Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD et al (2008) Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70:1176–1182
Franckena M, Lutgens LC, Koper PC, Kleynen CE, van der Steen-Banasik EM, Jobsen JJ et al (2009) Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients. Int J Radiat Oncol Biol Phys 73:242–250
Gani C, Schroeder C, Heinrich V, Spillner P, Lamprecht U, Berger B et al (2016) Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer. Int J Hyperthermia 1–6
Geiger M, Strnad V, Lotter M, Sauer R (2002) Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer. Brachytherapy 1:149–153
Gellermann J, Wlodarczyk W, Hildebrandt B, Ganter H, Nicolau A, Rau B et al (2005) Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res 65:5872–5880
Gellermann J, Hildebrandt B, Issels R, Ganter H, Wlodarczyk W, Budach V et al (2006) Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer 107:1373–1382
Heijkoop ST, van Doorn HC, Stalpers LJ, Boere IA, van der Velden J, Franckena M et al (2014) Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation. Int J Hyperthermia 30:6–10
Hildebrandt B, Wust P, Drager J, Ludemann L, Sreenivasa G, Tullius SG et al (2004) Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study. Int J Hyperthermia 20:359–369
Hildebrandt B, Hegewisch-Becker S, Kerner T, Nierhaus A, Bakhshandeh-Bath A, Janni W et al (2005) Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German ‘Interdisciplinary Working Group on Hyperthermia’. Int J Hyperthermia 21:169–183
Issels RD (2008) Regional hyperthermia in high-risk soft tissue sarcomas. Curr Opin Oncol 20:438–443
Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC et al (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561–570
Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D et al (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079–3085
Juffermans JH, Hanssens PE, van Putten WL, van Rhoon GC, van Der Zee J (2003) Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect. Cancer 98:1759–1766
Kouloulias V, Plataniotis G, Kouvaris J, Dardoufas C, Gennatas C, Uzunoglu N et al (2005) Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol 28:91–99
Kouloulias V, Triantopoulou S, Uzunoglou N, Pistevou-Gompaki K, Barich A, Zygogianni A et al (2015) Hyperthermia is now included in the NCCN clinical practice guidelines for breast cancer recurrences: an analysis of existing data. Breast Care 10:109–116
Linthorst M, van Geel AN, Baaijens M, Ameziane A, Ghidey W, van Rhoon GC et al (2013) Re-irradiation and hyperthermia after surgery for recurrent breast cancer. Radiother Oncol 109:188–193
Linthorst M, Baaijens M, Wiggenraad R, Creutzberg C, Ghidey W, van Rhoon GC et al (2015) Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: results in 248 patients. Radiother Oncol 117:217–222
Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock DF, Buijsen J, Mastrigt GA et al (2010) Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev (3):CD006377
Milani V, Pazos M, Issels RD, Buecklein V, Rahman S, Tschoep K et al (2008) Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strahlenther Onkol 184:163–168
Mochiki E, Shioya M, Sakurai H, Andoh H, Ohno T, Aihara R et al (2007) Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding. Int J Hyperthermia 23:493–500
Oldenborg S, Griesdoorn V, van Os R, Kusumanto YH, Oei BS, Venselaar JL et al (2015) Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: size matters. Radiother Oncol 117:223–228
Ott OJ, Rodel C, Weiss C, Wittlinger M, Krause FS, Dunst J et al (2009) Radiochemotherapy for bladder cancer. Clin Oncol (R Coll Radiol) 21:557–565
Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O et al (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Eur Soc Hyperther Oncol Lancet 345:540–543
Rau B, Benhidjeb T, Wust P, Schlag PM (2002) Stellenwert der hyperthermie für die chirurgische onkologie (German). Viszeralchirurgie 37:379–384
Rietbroek RC, Schilthuis MS, Bakker PJ, van Dijk JD, Postma AJ, Gonzalez Gonzalez D et al (1997) Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 79:935–943
Schaffer M, Krych M, Pachmann S, Abdel-Rahman S, Schaffer PM, Ertl-Wagner B et al (2003) Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer – preliminary results. Onkologie 26:120–124
Schlemmer M, Lindner LH, Abdel-Rahman S, Issels RD (2004) Principles, technology and indication of hyperthermia and part body hyperthermia. Radiologe 44:301–309
Schroeder C, Gani C, Lamprecht U, von Weyhern CH, Weinmann M, Bamberg M et al (2012) Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone. Int J Hyperthermia 28:707–714
Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD et al (1998) Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40:287–295
Strnad V, Lotter M, Kreppner S, Fietkau R (2015) Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy: long-term results. Strahlenther Onkol 191:495–500
Tanis PJ, Doeksen A, van Lanschot JJ (2013) Intentionally curative treatment of locally recurrent rectal cancer: a systematic review. Can J Surg 56:135–144
Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V et al (2005) Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 181:35–41
Valdagni R, Amichetti M (1994) Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28:163–169
van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:1119–1125
van Meerten E, Franckena M, Wiemer E, van Doorn L, Kraan J, Westermann A et al (2015) Phase I study of cisplatin, hyperthermia, and lapatinib in patients with recurrent carcinoma of the uterine cervix in a previously irradiated area. Oncologist 20:241–242
Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35:731–744
Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–2432
Wiig JN, Larsen SG, Dueland S, Giercksky KE (2005) Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer. J Surg Oncol 92:70–75
Winter L, Oberacker E, Paul K, Ji Y, Oezerdem C, Ghadjar P et al (2015) Magnetic resonance thermometry: methodology, pitfalls and practical solutions. Int J Hyperthermia 1–13
Wittlinger M, Rodel CM, Weiss C, Krause SF, Kuhn R, Fietkau R et al (2009) Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 93:358–363
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ott, O.J., Schmidt, M. (2016). Hyperthermia and Reirradiation. In: Nieder, C., Langendijk, J. (eds) Re-Irradiation: New Frontiers. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2016_34
Download citation
DOI: https://doi.org/10.1007/174_2016_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41823-0
Online ISBN: 978-3-319-41825-4
eBook Packages: MedicineMedicine (R0)